We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
New York’s attorney general is suing Insys for deceptive marketing of the spray form of one of its fentanyl products, a move the state says is part of a multi-pronged strategy to address the addiction crisis. Read More
Three supermarket chains sued more than 20 generic drug manufacturers, including Actavis, Apotex, Mylan, Teva and Sandoz, alleging they engaged in a conspiracy to set prices. Read More
A Chicago jury found AbbVie not liable for an Arizona man’s pulmonary embolism that he blamed on AndroGel, the company’s testosterone replacement drug. Read More
A federal circuit court upheld a PTO Patent Trial and Appeal Board ruling that a Johnson & Johnson patent for Remicade, which earned the company nearly $7 billion in 2016, is invalid. Read More
A drug research firm is suing the FDA for $50 million, arguing the agency issued a disciplinary letter that “annihilated” the company based on evidence fabricated by a rogue employee. Read More
The Seventh Circuit Court of Appeals in Chicago declined to revive several lawsuits against Pfizer over its testosterone drug Depo-T that had previously been among thousands of complaints in multidistrict litigation against testosterone drug manufacturers. Read More
Five health systems representing hundreds of U.S. hospitals plan to establish their own non-profit generic drug company to address drug shortages and bring competition to the generic drug market. Read More
The suit alleges Cydan violated a September 2013 confidentiality agreement that barred the company from using the patients’ data for any reason beyond a possible joint venture. Read More
The co-conspirators also told doctors to have Medicare patients take medically unnecessary spinal facet joint injections to obtain prescriptions. Read More